Abstract A34: Beyond immune checkpoint: First-in-class antibody targeting soluble NKG2D ligand sMIC for cancer immunotherapy
Year: 2017
Type: conference-abstract
Source: Cancer Immunology Research
Institution: Medical University of South Carolina
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2593010745
